AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ACENOCOUMAROL
4 registrations across 4 African markets— 2 active
Markets with ACENOCOUMAROL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SINTROM 4MG COMPRIME QUADRISECABLE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LABORATOIRES JUVISE PHARMACEUTICALS | expired | Jan 2025 |
| SINTROM. Comprimé sécable / 4 MG | 🇹🇳Tunisia | MEDIUS AG | expired | Jun 2018 |
| SINTROM COMPRIME QUADRISECABLE | 🇲🇦Morocco | — | active | — |
| SINTROM comprimé / 4 mg | 🇸🇳Senegal | NOVARTIS PHARMA | active | — |
ACENOCOUMAROL in Africa — Regulatory Overview
ACENOCOUMAROL is registered across 4 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Morocco, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.